Axial Biotherapeutics
Boston, US · Founded 2013
Biotech
Founders & leadership
SK
SARKIS K. MAZMANIANDirector
JC
JAMES C. BLAIRDirector
RC
Ronald C. Renaud Jr.Director
DH
DAVID H. DONABEDIANCHIEF EXECUTIVE OFFICER OF THE ISSUER
MC
MICHELLE C. DIPPDirector
HC
Henry C. WolfDirector
Reported raises · per SEC filings
Form D private placements$19.4MraisedFeb 2025 · 29 investors · Pharmaceuticals
Rule 506(b)$11.1MraisedOct 2023 · 35 investors · Pharmaceuticals
Rule 506(b)$27.4MraisedOct 2021 · 38 investors · Pharmaceuticals
Rule 506(b)$7.8MraisedMay 2020 · 21 investors · Pharmaceuticals
Rule 506(b)$5MraisedJun 2019 · 1 investors · Pharmaceuticals
Rule 506(b)$20MraisedNov 2018 · 36 investors · Pharmaceuticals
Rule 506(b)$19.1MraisedJun 2017 · 16 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.